CureVac
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CureVac and buy or sell other stocks, ETFs, and their options commission-free!About CVAC
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy.
CEOAlexander Zehnder, MD, MBA
CEOAlexander Zehnder, MD, MBA
Employees983
Employees983
HeadquartersTübingen, Baden Wuerttemberg
HeadquartersTübingen, Baden Wuerttemberg
Founded2020
Founded2020
Employees983
Employees983
CVAC Key Statistics
Market cap1.05B
Market cap1.05B
Price-Earnings ratio6.48
Price-Earnings ratio6.48
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.72
52 Week high$5.72
52 Week low$2.48
52 Week low$2.48
Stock Snapshot
As of today, CureVac(CVAC) shares are valued at $4.66. The company's market cap stands at 1.05B, with a P/E ratio of 6.48.
During the trading day, CureVac(CVAC) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for CureVac(CVAC) stock has reached 0.
The stock's 52-week range extends from a low of $2.48 to a high of $5.72.
The stock's 52-week range extends from a low of $2.48 to a high of $5.72.
People also own
Based on the portfolios of people who own CVAC. This list is generated using Robinhood data, and it’s not a recommendation.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.